𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Predictors of a response to cyclosporine or leukocyte removal therapy in patients with refractory ulcerative colitis

✍ Scribed by Takafumi Ando; Osamu Watanabe; Ryuichi Furuta; Osamu Maeda; Yuji Nishio; Tsuyoshi Nishiwaki; Kenji Ina; Kazuo Kusugami; Hidemi Goto

Book ID
108988032
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
184 KB
Volume
17
Category
Article
ISSN
0915-5635

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Infliximab or cyclosporine as rescue the
Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: A retrospective observational study
✍ Mats SjΓΆberg; Andrea Walch; Mina Meshkat; Anders Gustavsson; Gunnar JΓ€rnerot; Ha πŸ“‚ Article πŸ“… 2012 πŸ› John Wiley and Sons 🌐 English βš– 136 KB πŸ‘ 1 views

Background: Cyclosporine (CsA) or infliximab (IFX) are used as rescue therapies in steroid-refractory, severe attacks of ulcerative colitis (UC). There are no data comparing the efficacy of these two alternatives. Methods: Outcome of rescue therapy was retrospectively studied in two cohorts of pati

Predictors of early response to inflixim
Predictors of early response to infliximab in patients with ulcerative colitis
✍ Marc Ferrante; SΓ©verine Vermeire; Konstantinos H. Katsanos; Maja Noman; Gert Van πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 183 KB πŸ‘ 1 views

## Background: Our objective is to report the outcome of infliximab (ifx) in ulcerative colitis (uc) patients from a single center and to identify predictors of early clinical response. ## Methods: The first 100 uc patients (45 female; median age, 37.9 years) who received ifx at a single center w